Citalopram
- Product NDC
- 0615-6512
- 11-digit product format
- 006156512
- Labeler code
- 0615
- Product ID
- 0615-6512_7d3a4bb2-fce0-43f1-88e3-e52ccf8133ec
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Citalopram
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA077048
- Marketing category
- ANDA
- Marketing start
- 2007-11-08
- Marketing end
- 0000-00-00
- Substance
- CITALOPRAM HYDROBROMIDE
- Active strength
- 40 mg/1
- Pharmacologic classes
- Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0615-6512-05 | 2021-04-09 | C162847 | 48780-1 | 9d75b9d0-3e56-f424-e053-dadaa90a57ce | e4968bb7-2218-4d8e-a716-bfb4deb01b69 |
| 0615-6512-31 | 2021-04-09 | C162847 | 48780-1 | 9d75b9d0-3e56-f424-e053-dadaa90a57ce | e4968bb7-2218-4d8e-a716-bfb4deb01b69 |
| 0615-6512-39 | 2021-04-09 | C162847 | 48780-1 | 9d75b9d0-3e56-f424-e053-dadaa90a57ce | e4968bb7-2218-4d8e-a716-bfb4deb01b69 |
| 0615-6512-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-3e56-f424-e053-dadaa90a57ce | e4968bb7-2218-4d8e-a716-bfb4deb01b69 |
| 0615-6512-31 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-3e56-f424-e053-dadaa90a57ce | e4968bb7-2218-4d8e-a716-bfb4deb01b69 |
| 0615-6512-39 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-3e56-f424-e053-dadaa90a57ce | e4968bb7-2218-4d8e-a716-bfb4deb01b69 |